These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27601163)

  • 41. Eukaryotic initiation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer.
    Zhou S; Wang GP; Liu C; Zhou M
    BMC Cancer; 2006 Sep; 6():231. PubMed ID: 17010208
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overexpression of WAVE3 promotes tumor invasiveness and confers an unfavorable prognosis in human hepatocellular carcinoma.
    Ji Y; Li B; Zhu Z; Guo X; He W; Fan Z; Zhang W
    Biomed Pharmacother; 2015 Feb; 69():409-15. PubMed ID: 25661390
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
    Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resection.
    Wu H; Chen P; Liao R; Li YW; Yi Y; Wang JX; Sun TW; Zhou J; Shi YH; Yang XR; Jin JJ; Cheng YF; Fan J; Qiu SJ
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1312-9. PubMed ID: 22432916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human U Three Protein 14a Expression is Increased in Hepatocellular Carcinoma and Associated with Poor Prognosis.
    Zhang JY; Xu D; Liu ZZ; Li Y; Wang LJ; Xing BC
    Chin Med J (Engl); 2017 Feb; 130(4):470-476. PubMed ID: 28218222
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low expression of B-cell-associated protein 31 in human primary hepatocellular carcinoma correlates with poor prognosis.
    Tan N; Liu Q; Liu X; Gong Z; Zeng Y; Pan G; Xu Q; He S
    Histopathology; 2016 Jan; 68(2):221-9. PubMed ID: 25980696
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Coexpression of stemness factors Oct4 and Nanog predict liver resection.
    Yin X; Li YW; Zhang BH; Ren ZG; Qiu SJ; Yi Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2877-87. PubMed ID: 22461131
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overexpression Of Hepatocyte Nuclear Factor-1beta Predicting Poor Prognosis Is Associated With Biliary Phenotype In Patients With Hepatocellular Carcinoma.
    Yu DD; Jing YY; Guo SW; Ye F; Lu W; Li Q; Dong YL; Gao L; Yang YT; Yang Y; Wu MC; Wei LX
    Sci Rep; 2015 Aug; 5():13319. PubMed ID: 26311117
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of eukaryotic initiation factor 4E phosphorylation by cercosporamide selectively suppresses angiogenesis, growth and survival of human hepatocellular carcinoma.
    Liu Y; Sun L; Su X; Guo S
    Biomed Pharmacother; 2016 Dec; 84():237-243. PubMed ID: 27662474
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical Significance of Eukaryotic Initiation Factor 4E (eIF4E) Level among Cases Suffering Basal Cell Carcinoma of Skin.
    Han B; Zhang Q; Li G; Zhang R; Li H
    Med Sci Monit; 2019 Oct; 25():7936-7941. PubMed ID: 31641096
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma.
    Peng W; Fan H
    Biomed Pharmacother; 2015 May; 72():113-8. PubMed ID: 26054684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
    Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
    Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diacylglycerol kinase alpha enhances hepatocellular carcinoma progression by activation of Ras-Raf-MEK-ERK pathway.
    Takeishi K; Taketomi A; Shirabe K; Toshima T; Motomura T; Ikegami T; Yoshizumi T; Sakane F; Maehara Y
    J Hepatol; 2012 Jul; 57(1):77-83. PubMed ID: 22425622
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low CDX1 expression predicts a poor prognosis for hepatocellular carcinoma patients after hepatectomy.
    Zheng H; Yang Y; Wang MC; Yuan SX; Tian T; Han J; Ni JS; Wang J; Xing H; Zhou WP
    Surg Oncol; 2016 Sep; 25(3):171-7. PubMed ID: 27566019
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thrombospondin-4 expression as a prognostic marker in hepatocellular carcinoma.
    Wu H; Zhang G; Li Z; Ma J; Han X; Xiang T; Jiang X
    Gene; 2019 May; 696():219-224. PubMed ID: 30802535
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low expression of NEK2 is associated with hepatocellular carcinoma progression and poor prognosis.
    Fu L; Liu S; Wang H; Ma Y; Li L; He X; Mou X; Tong X; Hu Z; Ru G
    Cancer Biomark; 2017 Jul; 20(1):101-106. PubMed ID: 28759960
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elevated levels of p-Mnk1, p-eIF4E and p-p70S6K proteins are associated with tumor recurrence and poor prognosis in astrocytomas.
    Fan W; Wang W; Mao X; Chu S; Feng J; Xiao D; Zhou J; Fan S
    J Neurooncol; 2017 Feb; 131(3):485-493. PubMed ID: 27900644
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic value of peritumoral heat-shock factor-1 in patients receiving resection of hepatocellular carcinoma.
    Zhang JB; Guo K; Sun HC; Zhu XD; Zhang B; Lin ZH; Zhang BH; Liu YK; Ren ZG; Fan J
    Br J Cancer; 2013 Sep; 109(6):1648-56. PubMed ID: 24002609
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of Pregnancy Up-regulated Non-ubiquitous Calmodulin Kinase (PNCK) in Hepatocellular Carcinoma.
    Cho YA; Choi S; Park S; Park CK; Ha SY
    Cancer Genomics Proteomics; 2020; 17(6):747-755. PubMed ID: 33099476
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human growth hormone and human prolactin function as autocrine/paracrine promoters of progression of hepatocellular carcinoma.
    Kong X; Wu W; Yuan Y; Pandey V; Wu Z; Lu X; Zhang W; Chen Y; Wu M; Zhang M; Li G; Tan S; Qian P; Perry JK; Lobie PE; Zhu T
    Oncotarget; 2016 May; 7(20):29465-79. PubMed ID: 27102295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.